Gerresheimer Stock - Analyst views and sector check into the weekend

Gerresheimer stock draws a cautious end-of-week review as investors weigh the packaging specialist’s role in the healthcare supply chain, analyst expectations and the broader medtech and pharma services sector.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:20 CET. Details in the imprint.

Gerresheimer (DE000A0LD6E6) sits at the intersection of pharmaceutical packaging and medical technology services for global drugmakers. With no fresh ad-hoc releases or major rating changes reported by leading wires or brokerages today, the end-of-week view centers on consensus expectations and the broader healthcare packaging sector.

How analysts frame Gerresheimer

Recent broker commentary, as compiled on major financial portals, reflects a broadly constructive but selective stance on Gerresheimer, with many houses highlighting its exposure to injectable drugs, biologics and GLP-1 therapies as structural drivers for specialized packaging demand.

The consensus picture sketched on several data platforms points to expectations of moderate revenue growth paired with a gradual margin improvement over the next few years, underpinned by capacity expansions and a richer mix of solutions for pharma customers.

Position in the healthcare packaging sector

Against the wider backdrop, Gerresheimer competes with international peers in primary pharmaceutical packaging, medical devices components and drug delivery systems, a niche where switching costs and regulatory approvals can support relatively stable customer relationships.

For the week, many investors are comparing Gerresheimer’s valuation multiples with those of broader healthcare suppliers and device makers, assessing whether its mix of growth projects and recurring packaging business justifies a sector-level or modest premium rating.

How the company makes money

Gerresheimer primarily generates revenue by supplying primary packaging such as glass and plastic vials, syringes and containers, as well as complex drug delivery systems and medical plastic systems for pharmaceutical and biotechnology clients worldwide.

Where the stock trades today

The shares of Gerresheimer (DE000A0LD6E6) trade on Xetra at EUR 100.00 as of 06/19/2026, 15:20 CET.

Key facts on Gerresheimer stock

• Company: Gerresheimer AG
• ISIN: DE000A0LD6E6
• WKN: A0LD6E
• Ticker: GXI
• Venue: Xetra
• Price (as of 06/19/2026, 15:20 CET): 100.00 EUR
• Market cap: 3,200,000,000 EUR (as of 06/19/2026)
• Sector / Industry: Health Care - Medical Supplies & Pharmaceuticals Packaging
• Index membership: MDAX, Stoxx Europe 600
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.